Contribution: Industrial Research Assistance Program – Contributions to Firms
Ananda Devices Inc.
$699,000.00
Neuromuscular junction-on-a-chip for rapid diagnosis of neuromuscular diseases and applications in precision medicine
FY 2022-23 · 2022-09-26
Summary
Neuromuscular diseases (NMDs) affect approximately 13 million worldwide, there is no cure and no effective therapy. There is a major need for robust, scalable, and reproducible in vitro models of human neuromuscular junctions (NMJ) to test therapeutic candidates. Ananda Devices, guided by the needs from the top pharmaceutical company in this market, developed a first-in-class, patent protected technology that enables the establishment of a highly standardized human NMJ in vitro. In this project, we scale up this platform with high reproducibility and quality.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Montreal|Montreal, Quebec, Canada
Recipient Type
For-profit organization
Business Number
799217898
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 1 | 2022-09-26 | 2022-23 | $285,000.00 |
| 3 | 2022-09-26 | 2022-23 | $699,000.00 |
| 4 | 2022-09-26 | 2022-23 | $699,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 90 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 90 jours.
Agreement End Date
2024-03-14
Agreement Number
997002
Agreement Start Date
2022-09-26
Agreement Title
Neuromuscular junction-on-a-chip for rapid diagnosis of neuromuscular diseases and applications in precision medicine
Agreement Title (French)
Jonction neuromusculaire sur puce pour le diagnostic rapide des maladies neuromusculaires et applications en médecine de précision
Agreement Type
Contribution
Agreement Value
$699,000.00
Amendment Date
2023-11-30
Amendment Number
4
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Neuromuscular diseases (NMDs) affect approximately 13 million worldwide, there is no cure and no effective therapy. There is a major need for robust, scalable, and reproducible in vitro models of human neuromuscular junctions (NMJ) to test therapeutic candidates. Ananda Devices, guided by the needs from the top pharmaceutical company in this market, developed a first-in-class, patent protected technology that enables the establishment of a highly standardized human NMJ in vitro. In this project, we scale up this platform with high reproducibility and quality.
Description (French)
Les maladies neuromusculaires (MNM) touchent environ 13 millions de personnes dans le monde, il n’existe pas de traitement curatif ni de thérapie efficace. Il existe un besoin important de modèles in vitro robustes, évolutifs et reproductibles de jonctions neuromusculaires humaines (JNH) pour tester les candidats thérapeutiques. Ananda Devices, guidée par les besoins de la principale société pharmaceutique sur ce marché, a développé une technologie brevetée, première de sa catégorie, qui permet d’établir une JNH hautement standardisée in vitro. Dans ce projet, nous mettons à l’échelle cette plateforme en assurant une reproductibilité et une qualité élevées.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Saint-Laurent
Federal Riding (French)
Saint-Laurent
Federal Riding Number
24068
NAICS Code
54199
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
799217898
Recipient City
Montreal|Montreal
Recipient Country
CA
Recipient Legal Name
Ananda Devices Inc.
Recipient Operating Name
ANANDA Devices
Recipient Postal Code
H4R 3E9
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2022-2023-Q3-997002
